UNDATED (AP) – CVS has halted sales of popular heartburn treatment Zantac and the store generic version after warnings by U.S. health regulators. CVS is the latest retailer to pull the heartburn tablets from store shelves. Earlier this month, the U.S. Food and Drug Administration warned consumers about a potentially dangerous contaminant in prescription and over-the-counter versions of Zantac.